- Agoura Hills, CA & Encino, CA
Breakthroughs in treatment-resistant depression are at the forefront of our mission, and we understand the weight that depression can place on every aspect of your life. At Yofi Mind Health, we proudly offer Spravato, an FDA-approved and cutting-edge depression treatment that is changing lives.
Spravato is an FDA-approved prescription nasal spray medication containing esketamine, used for treating adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. This treatment is most often used in tandem with an oral antidepressant.
It’s administered through a nasal spray device under medical supervision in a healthcare setting, offering a novel approach for those who have not responded adequately to traditional antidepressants.
Esketamine, the active ingredient, is related to ketamine, a medication known for its rapid-acting antidepressant effects.
Spravato offers a unique and innovative treatment for those battling treatment-resistant depression, highlighted by several key benefits:
Are you tired of dealing with your depression symptoms? Have you tried different types of medications that provided no results? Do not lose hope. We can help with Spravato (esketamine) nasal spray!
During your treatment, you will be safely monitored at our office in a private room. We will give you an eye mask (or optional VR glasses) and blanket while you either meditate in silence or listen to soft music. Spravato is fast-acting, often providing rapid relief.
Patients treated with Spravato often describe the feeling as a meditative, euphoric, or trance state. Similarly to Ketamine infusions, Spravato helps approach your issues from a unique perspective.
You might not be a good candidate for Spravato treatment if you have a history of aneurysmal vascular disease, arteriovenous malformation, bleeding in the brain, or are allergic to esketamine or any of its components.
Additionally, if you have uncontrolled high blood pressure, severe liver problems, or a history of psychosis, you may be advised against this treatment.
Pregnant or breastfeeding women should also avoid Spravato due to potential risks to the baby.
It’s essential for patients to discuss their full medical history and concerns with their healthcare provider so they can do a risk evaluation and ensure Spravato is a safe option.
These potential side effects underscore the importance of discussing all potential risks and benefits with one of our skilled healthcare providers before starting Spravato.
To start Spravato treatment, patients first need a diagnosis of treatment-resistant depression from a healthcare provider. Following this, a consultation with a specialist certified to administer Spravato is necessary.
Pre-treatment assessments, including health history and potential risk factors, are crucial for tailoring the treatment plan.
If deemed appropriate, patients will undergo treatment in a certified medical facility, where they will be closely monitored by healthcare professionals.
Continuous follow-up appointments with a personalized treatment schedule are essential for monitoring response and adjusting the treatment as needed.
Spravato is approved for adults with major depressive disorder (MDD) who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD). Adults with depressive symptoms coupled with suicidal thoughts or actions (MDSI) also qualify.
Spravato’s mechanism of action is unlike traditional medications. Whereas most oral antidepressants work on the serotonin receptor (SSRIs, for example) and may have many negative side effects, Spravato works through a different pathway. Spravato (esketamine) is an NMDA receptor antagonist, which means it works by modulating the activity of the neurotransmitter glutamate. Glutamate is involved in the communication between nerve cells and is associated with the formation of new neural connections and pathways.
Spravato is believed to promote neuroplasticity, which is the brain’s ability to reorganize itself by forming new neural connections. This process plays a role in the alleviation of depressive symptoms.
Spravato is FDA-approved and safe to use. Side effects include sleepiness (sedation), dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space, and time (dissociation), and they usually resolve before you leave the office.
Antidepressant medicines may increase suicidal thoughts and actions, especially within the first few months of treatment or when the dose is changed. Spravato is not for use in children.
The duration of Spravato (esketamine) effects can vary from person to person, and it depends on several factors, including the individual’s metabolism, the dosage administered, and the specific characteristics of their depression.
Yes! Spravato is covered here at Yofi. Medicare and most PPO insurances cover the cost of Spravato therapy. We are in-network with many major PPO insurance companies in California.
You will take Spravato nasal spray yourself, under the supervision of one of our expert providers in one of our comfortable treatment rooms. You will have your own private room, each room equipped with a comfortable chair, blankets, galaxy lights, headphones and music, VR options, and more. Throughout your treatment, you will be closely monitored to ensure your comfort and safety.
At Yofi Mind Health, we also offer Ketamine Infusion Therapy and Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression.
Don’t let depression dictate your story any longer. Take the first step towards a life of renewed vitality and joy by exploring the possibilities with Spravato.
Request A Free Consultation Today And A Member Of Our Staff Will Get Back With You
© 2024 All Rights Reserved. Privacy Policy | Accessibility Policy | Open Payments Database